Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies

Massimiliano Berretta, Agnieszka Micek, Alessandra Lafranconi, Sabrina Rossetti, Raffaele Di Francia, Paolo De Paoli, Paola Rossi, Gaetano Facchini

Research output: Contribution to journalArticle

Abstract

Background: Coffee consumption has been associated with numerous cancers, but evidence on ovarian cancer risk is controversial. Therefore, we performed a meta-analysis on prospective cohort studies in order to review the evidence on coffee consumption and risk of ovarian cancer.

Methods: Studies were identified through searching the PubMed and MEDLINE databases up to March 2017. Risk estimates were retrieved from the studies, and dose-response analysis was modelled by using restricted cubic splines. Additionally, a stratified analysis by menopausal status was performed.

Results: A total of 8 studies were eligible for the dose-response meta-analysis. Studies included in the analysis comprised 787,076 participants and 3,541 ovarian cancer cases. The results showed that coffee intake was not associated with ovarian cancer risk (RR = 1.06, 95% CI: 0.89, 1.26). Stratified and subgroup analysis showed consisted results.

Conclusions: This comprehensive meta-analysis did not find evidence of an association between the consumption of coffee and risk of ovarian cancer.

Original languageEnglish
Pages (from-to)20807-20815
Number of pages9
JournalOncotarget
Volume9
Issue number29
DOIs
Publication statusPublished - Apr 17 2018

Fingerprint Dive into the research topics of 'Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies'. Together they form a unique fingerprint.

  • Cite this